NEKTAR THERAPEUTICS — Director's Dealing 2013

Jan 30, 2013

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2012-12-31

Reporting Person: WHITFIELD ROY A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-12-27	Common Stock	G	20000	—	Disposed	0	Direct
2012-12-27	Common Stock	G	20000	—	Acquired	20000	Indirect

Footnotes

F1: This transaction involved a gift of shares by Mr. Whitfield to a trust for the benefit of Mr. Whitfield's children. Mr. Whitfield is the sole trustee of this trust.